Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Other, Diagnostic Test, Drug
  • Participants: 20
  • Start Date: September 2021
Pilot Trial About the Effects of Calcitriol's Treatment in the Neurological Function and Frataxin's Level in Friedreich's Ataxia Patients
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: April 10, 2021
A Phase 2a Study of NAD+ Precursor Supplementation in Friedreich's Ataxia
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 6
  • Start Date: February 15, 2021
Vasculopathy and Remodeling of Coronary Arteries in FRDA Patients
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 300
  • Start Date: February 10, 2021
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals With Friedreich Ataxia (TRACK-FA)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Behavioral
  • Participants: 50
  • Start Date: January 1, 2021
Home Based Tele-exercise for People With Chronic Neurological Impairments
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 126
  • Start Date: November 23, 2020
A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: September 17, 2020
A Phase 2 Clinical Trial to Test the Safety and Efficacy of Etravirine in Friedreich Ataxia Patients
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other, Dietary Supplement
  • Participants: 72
  • Start Date: September 3, 2020
NAD+ Precursor Supplementation With Exercise Training to Increase Aerobic Capacity in Friedreich's Ataxia
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 30
  • Start Date: July 31, 2020
A Phase 1 Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
Clinical Trial
  • Status: Recruiting
  • Participants: 1000
  • Start Date: July 1, 2020
Biomarker for Friedreich's Ataxia: An International, Multicenter, Observational, Longitudinal Protocol
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 225
  • Start Date: March 2020
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Other
  • Participants: 120
  • Start Date: March 1, 2020
Characterization of the Interruptions of the GAA Expansion and Study of Their Influence on the Severity of Friedreich's Ataxia : INTREP-AF
Showing 1-12 of 27